Breaking News, Collaborations & Alliances

Starpharma, AstraZeneca In Discovery Alliance

Will study Starpharma’s dendrimer technology in cancer

Starpharma Holdings Ltd. and AstraZeneca have entered an agreement under which AstraZeneca will test certain Starpharma oncology molecules based on Starpharma’s dendrimer technology. AstraZeneca will conduct studies using specific Starpharma drug-dendrimer conjugate molecules and assess the suitability of the dendrimer constructs for applications in the cancer field.
 
Neither the molecules to be studied nor further details of the agreement were disclosed.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters